NEPHROGENEX INC - COM (NRXGQ)

CUSIP: 640667101

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM
Total 13F shares
2,623,718
Share change
+409,708
Total reported value
$8,869,000
Price per share
$3.38
Number of holders
12
Value change
+$1,138,757
Number of buys
10
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP 640667101?
CUSIP 640667101 identifies NRXGQ - NEPHROGENEX INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEPHROGENEX INC - COM (NRXGQ) as of Q3 2015

As of 30 Sep 2015, NEPHROGENEX INC - COM (NRXGQ) was held by 12 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,623,718 shares. The largest 10 holders included RHO CAPITAL PARTNERS INC, Visium Asset Management, LP, TURNER INVESTMENTS, L.P., MORGAN STANLEY, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, JPMORGAN CHASE & CO, BlackRock Fund Advisors, BANK OF AMERICA CORP /DE/, and Vantage Investment Advisors, LLC. This page lists 12 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.